InvestorsHub Logo
Followers 46
Posts 839
Boards Moderated 0
Alias Born 10/29/2013

Re: None

Monday, 03/31/2014 7:30:10 AM

Monday, March 31, 2014 7:30:10 AM

Post# of 1000
Hello people,

I have actually a good feeling of approval for this drug. Seems that a drug ("Sonazoid") with the same active substance (perflubutane) has been approved by the Japanese FDA in 2007 and expanded for detection use of breast cancer in 2012

(http://www.firstwordmedtech.com/node/936259?tsid=17)

Imagify was first in application for USA and Europe, so big chance their Acusphere's product get's approved first.

Also GE Healthcare is marketing this drug in Japan, so if AI-700 get's approved in USa and/or Europe, Acusphere would become an interesting buy out target for them IMO.

Here also annual sales figures from Japan in 2010 and 2011 (bear in mind that in Europe and US cardiavascualair disease is more common):

http://www.evaluategroup.com/Universal/View.aspx?type=Entity&entityType=Product&id=15100&lType=modData&componentID=1002

Greetings Tanja